Silvin Lito1, Adama Sidibe2, Sten Ilmjarv1, Patricie Burda3, Matthias Baumgartner3, Bernhard Wehrle-Haller2, Karl-Heinz Krause1, Antoine Marteyn1. 1. Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, CH-1211 Geneva 4, Switzerland. 2. Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, CH-1211 Geneva 4, Switzerland. 3. Division of Metabolism and Children's Research Center, University Children's Hospital, CH-8032 Zürich, Switzerland.
Abstract
Background: Mucopolysaccharidosis type I-Hurler (MPS1-H) is a severe genetic lysosomal storage disorder due to loss-of-function mutations in the IDUA gene. The subsequent complete deficiency of alpha l-iduronidase enzyme is directly responsible of a progressive accumulation of glycosaminoglycans (GAG) in lysosomes which affects the functions of many tissues. Consequently, MPS1 is characterized by systemic symptoms (multiorgan dysfunction) including respiratory and cardiac dysfunctions, skeletal abnormalities and early fatal neurodegeneration. Methods: To understand mechanisms underlying MPS1 neuropathology, we generated induced pluripotent stem cells (iPSC) from a MPS1-H patient with loss-of-function mutations in both IDUA alleles. To avoid variability due to different genetic background of iPSC, we established an isogenic control iPSC line by rescuing IDUA expression by a lentivectoral approach. Results: Marked differences between MPS1-H and IDUA-corrected isogenic controls were observed upon neural differentiation. A scratch assay revealed a strong migration defect of MPS1-H cells. Also, there was a massive impact of IDUA deficiency on gene expression (340 genes with an FDR <0.05). Conclusions: Our results demonstrate a hitherto unknown connection between lysosomal degradation, gene expression and neural motility, which might account at least in part for the phenotype of MPS1-H patients.
Background: Mucopolysaccharidosis type I-Hurler (MPS1-H) is a severe genetic lysosomal storage disorder due to loss-of-function mutations in the IDUA gene. The subsequent complete deficiency of alpha l-iduronidase enzyme is directly responsible of a progressive accumulation of glycosaminoglycans (GAG) in lysosomes which affects the functions of many tissues. Consequently, MPS1 is characterized by systemic symptoms (multiorgan dysfunction) including respiratory and cardiac dysfunctions, skeletal abnormalities and early fatal neurodegeneration. Methods: To understand mechanisms underlying MPS1 neuropathology, we generated induced pluripotent stem cells (iPSC) from a MPS1-H patient with loss-of-function mutations in both IDUA alleles. To avoid variability due to different genetic background of iPSC, we established an isogenic control iPSC line by rescuing IDUA expression by a lentivectoral approach. Results: Marked differences between MPS1-H and IDUA-corrected isogenic controls were observed upon neural differentiation. A scratch assay revealed a strong migration defect of MPS1-H cells. Also, there was a massive impact of IDUA deficiency on gene expression (340 genes with an FDR <0.05). Conclusions: Our results demonstrate a hitherto unknown connection between lysosomal degradation, gene expression and neural motility, which might account at least in part for the phenotype of MPS1-H patients.
Authors: Jakub Tolar; In-Hyun Park; Lily Xia; Chris J Lees; Brandon Peacock; Beau Webber; Ron T McElmurry; Cindy R Eide; Paul J Orchard; Michael Kyba; Mark J Osborn; Troy C Lund; John E Wagner; George Q Daley; Bruce R Blazar Journal: Blood Date: 2010-10-29 Impact factor: 22.113
Authors: Qiurong Ding; Youn-Kyoung Lee; Esperance A K Schaefer; Derek T Peters; Adrian Veres; Kevin Kim; Nicolas Kuperwasser; Daniel L Motola; Torsten B Meissner; William T Hendriks; Marta Trevisan; Rajat M Gupta; Annie Moisan; Eric Banks; Max Friesen; Robert T Schinzel; Fang Xia; Alexander Tang; Yulei Xia; Emmanuel Figueroa; Amy Wann; Tim Ahfeldt; Laurence Daheron; Feng Zhang; Lee L Rubin; Lee F Peng; Raymond T Chung; Kiran Musunuru; Chad A Cowan Journal: Cell Stem Cell Date: 2012-12-13 Impact factor: 24.633
Authors: Anselme L Perrier; Viviane Tabar; Tiziano Barberi; Maria E Rubio; Juan Bruses; Norbert Topf; Neil L Harrison; Lorenz Studer Journal: Proc Natl Acad Sci U S A Date: 2004-08-13 Impact factor: 11.205
Authors: Susan L Staba; Maria L Escolar; Michele Poe; Young Kim; Paul L Martin; Paul Szabolcs; June Allison-Thacker; Susan Wood; David A Wenger; Pablo Rubinstein; John J Hopwood; William Krivit; Joanne Kurtzberg Journal: N Engl J Med Date: 2004-05-06 Impact factor: 91.245
Authors: Evgeny D Nekrasov; Vladimir A Vigont; Sergey A Klyushnikov; Olga S Lebedeva; Ekaterina M Vassina; Alexandra N Bogomazova; Ilya V Chestkov; Tatiana A Semashko; Elena Kiseleva; Lyubov A Suldina; Pavel A Bobrovsky; Olga A Zimina; Maria A Ryazantseva; Anton Yu Skopin; Sergey N Illarioshkin; Elena V Kaznacheyeva; Maria A Lagarkova; Sergey L Kiselev Journal: Mol Neurodegener Date: 2016-04-14 Impact factor: 14.195